Skip to main content
PIRAMAL PHARMA LIMITED logo

PIRAMAL PHARMA LIMITED — Investor Relations & Filings

Ticker · PPLPHARMA ISIN · INE0DK501011 LEI · 3358006D6AL7PZ4U9T51 BSE.NS Manufacturing
Open in API
Filings indexed 367 across all filing types
Latest filing 2024-10-22 Regulatory Filings
Country IN India
Listing BSE.NS PPLPHARMA

About PIRAMAL PHARMA LIMITED

https://www.piramalpharma.com/

Piramal Pharma Limited provides a broad range of products and services across the drug lifecycle through three main business segments: Piramal Pharma Solutions, Piramal Critical Care, and Consumer Healthcare. Piramal Pharma Solutions operates as an integrated Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from drug discovery and development to commercial manufacturing of APIs and formulations. Piramal Critical Care focuses on complex hospital generics, holding a significant global market share in inhalation anesthetics, including Sevoflurane and Isoflurane, as well as injectable anesthesia and pain management therapies. The Consumer Healthcare division manages a diverse portfolio of over-the-counter brands such as Saridon, Lacto Calamine, and Tetmosol. The company leverages an extensive global manufacturing network to deliver specialized healthcare solutions worldwide.

Recent filings

Filing Released Lang Actions
Credit Rating- New
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a credit rating assigned by ICRA Limited to the company's prospective commercial paper. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which pertains to disclosure of material events. The document does not contain financial statements, detailed financial data, or a report itself. It is an update on a rating action, which is a regulatory announcement. The document length is only 1372 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-22 English
Action(s) taken or orders passed
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI Listing Regulations regarding a compounding order received from a legal authority related to a violation under the Legal Metrology Act. It is an announcement of a regulatory/legal matter and does not contain financial statements, management discussion, or detailed financial data. The document is short (1789 characters) and serves as a regulatory announcement about a legal compliance issue. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-21 English
Board Meeting — PIRAMAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for th…
Regulatory Filings
2024-10-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an announcement dated 14th October 2024 from Piramal Pharma Limited regarding an upcoming conference call with investors and analysts scheduled for 24th October 2024 to discuss the Q2 and H1 FY2025 financial results. It provides dial-in details and general company information but does not contain any actual financial data or the transcript of the call itself. The document is short (3726 characters) and serves to inform about the event rather than present financial results or detailed analysis. According to the classification rules, such announcements about upcoming conference calls are best classified as Call Transcript (CT) only if they contain the full transcript, which this does not. Instead, this is an announcement of the call. However, there is no specific category for a conference call announcement alone. The closest and most appropriate category is Regulatory Filings (RNS) as a general regulatory announcement under SEBI Listing Regulations. Therefore, the document is classified as Regulatory Filings (RNS) with high confidence.
2024-10-14 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice dated 14th October 2024 addressed to stock exchanges (BSE and NSE) regarding an upcoming Board Meeting scheduled for 23rd October 2024. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2024. It also mentions the closure of the trading window for securities dealing. The document does not contain any actual financial data or detailed financial statements; it is an announcement about the timing and agenda of a board meeting where financial results will be approved. The length is only 1769 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement informing the market about an upcoming event related to financial results, but not the results themselves or a detailed report.
2024-10-14 English
Action(s) taken or orders passed
Regulatory Filings Classification · 95% confidence The document is a notification under Regulation 30 of the SEBI Listing Regulations, which requires listed companies to inform stock exchanges about material events or information. The content describes receipt of assessment orders related to a tax penalty from a local municipal corporation concerning a subsidiary acquired earlier. It states the company is assessing the orders and that there is no material impact on financials or operations. The document is an announcement of a regulatory event rather than a financial report or detailed filing. It is short (2196 characters) and serves as an intimation to stock exchanges. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance documents that do not fit other specific categories.
2024-10-10 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.